Tuoxin Pharmaceutical: Plans to establish a wholly-owned subsidiary with a registered capital of 50 million yuan

Tuoxin Pharmaceutical announced that at the eighth meeting of the fifth board of directors held on October 28, 2025, it reviewed and approved the proposal on establishing a subsidiary through external investment. The company plans to set up a wholly-owned subsidiary named "Tuoxin Pharmaceutical Co., Ltd." in Tokto County, Hohhot City, Inner Mongolia Autonomous Region, with a registered capital of 50 million yuan. The new company will focus on the research, development, production, and sales of fermentation-related products, centered around the company's core business. The funds for this external investment will be entirely sourced from the company's own or self-raised funds, and the company will hold 100% equity in it